Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I’m seeing the exact same thing in my department. It used to be that we could order routine reagents without a second thought, but now even basic bench supplies require a deep dive justification and management sign-off. It’s incredibly frustrating when you’re trying to hit project milestones and you’re blocked by a procurement process that feels more concerned with optics than actual output. If this is the new normal, I honestly don't know how they expect us to maintain the pace of innovation they keep promising in the quarterly calls.
Honestly, it’s just the usual cyclical belt-tightening we see every few years. Every time the pressure builds to improve the margins, the lab budget is always the first place they swing the axe. It’s annoying, but don’t take it too personally—it’s just the corporate machine trying to keep the balance sheet looking pretty for the shareholders. Just document every delay and keep your project status reports updated so it’s clear where the bottleneck is if a deadline gets pushed. It's not our fault if they refuse to fund the tools we need to do the job.